Evidence map›Paper›PMID 37096914›Full record

ArticleGut microbes

Epidemiological and microbiome associations of

Jyoti Mani, Shira Levy, Angelina Angelova, Sahel Hazrati, Ryan Fassnacht, Poorani Subramanian, Tiana Richards, John E Niederhuber, George L Maxwell, Suchitra K Hourigan

Abstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. The prevalence and molecular epidemiology ofEmerging microbes & infections · 2026
    Observational
  3. Comparative genomic analysis ofMicrobial genomics · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Understanding the influence of the microbiome on childhood infections.Expert review of anti-infective therapy · 2024
    Review
  11. One health (Amsterdam, Netherlands) · 2024
    Article
  12. Article
  13. Article
  14. Gut Microbiota Composition andGut microbes reports · 2024
    Article
  15. Review
  16. [Advances in the treatment ofZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jyoti ManiDepartment of Pediatrics, Children's National Medical Center, Washington, DC, USA.
Shira LevyNational Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA.
Angelina AngelovaNational Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA.
Sahel HazratiWomen's Service Line, Inova Health System, Falls Church, VA, USA.
Ryan FassnachtInova Children's Hospital, Inova Health System, Falls Church, VA, USA.
Poorani SubramanianNational Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA.
Tiana RichardsInova Children's Hospital, Inova Health System, Falls Church, VA, USA.
John E NiederhuberInova Children's Hospital, Inova Health System, Falls Church, VA, USA.
George L MaxwellWomen's Service Line, Inova Health System, Falls Church, VA, USA.
Suchitra K HouriganNational Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA.

Funding

The role of the microbiome in childhood diseaseZIAAI001362 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HOURIGAN, SUCHITRA · 2022 to 2025
$2.5M
The contribution of antibiotic exposure in the prenatal, peripartum and infancy period to intestinal microbiome perturbations and association with early childhood obesity.K23HD099240 · NICHD · INOVA HEALTH CARE SERVICES · PI HOURIGAN, SUCHITRA · 2019 to 2021
$476k
NICHD NIH HHS K23 HD099240
6 · The paper itself

Abstract

There has been an increase in the prevalence of Clostridioides difficile (C. diff) causing significant economic impact on the health care system. Although toxigenic C. diff carriage is recognized in infancy, there is limited data regarding its longitudinal trends, associated epidemiolocal risk factors and intestinal microbiome characteristics. The objectives of our longitudinal cohort study were to investigate temporal changes in the prevalence of toxigenic C.diff colonization in children up to 2 years, associated epidemiological and intestinal microbiome characteristics. Pregnant mothers were enrolled prenatally, and serial stool samples were collected from their children for 2 years. 2608 serial stool samples were collected from 817 children. 411/817 (50%) were males, and 738/817 (90%) were born full term. Toxigenic C.diff was detected in 7/569 (1%) of meconium samples, 116/624 (19%) of 2 m (month), 221/606 (37%) of 6 m, 227/574 (40%) of 12 m and 18/235 (8%) of 24 m samples. Infants receiving any breast milk at 6 m were less likely to be carriers at 2 m, 6 m and 12 m than those not receiving it. (

Indexed as

Clostridioides difficileClostridium InfectionsGastrointestinal MicrobiomeChildChild, PreschoolClostridioidesFecesFemaleHumansInfantLongitudinal StudiesMaleMilk, HumanchildrenClostridiodes difficileEpidemiologyinfantsmicrobiome

Identifiers

PMID37096914
PMCPMC10132246

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.